Amundi
TEVA icon

Amundi’s Teva Pharmaceuticals TEVA Stock Holding History

Amundi’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.4M Buy
1,929,853
+164,167
+9% +$5.47M 0.02% 554
2026
Q1 		$53.2M Sell
1,765,686
-1,463,440
-45% -$47.1M 0.01% 583
2025
Q4 		$101M Buy
3,229,126
+2,011,914
+165% +$49.6M 0.03% 488
2025
Q3 		$24.3M Sell
1,217,212
-106,211
-8% -$1.87M 0.01% 697
2025
Q2 		$22.6M Buy
1,323,423
+644,665
+95% +$10.4M 0.01% 690
2025
Q1 		$10.1M Buy
678,758
+105,846
+18% +$1.89M ﹤0.01% 830
2024
Q4 		$12.3M Sell
572,912
-80,958
-12% -$1.47M ﹤0.01% 810
2024
Q3 		$11.5M Sell
653,870
-701
-0.1% -$12.3K ﹤0.01% 818
2024
Q2 		$11M Buy
654,571
+114,100
+21% +$1.76M ﹤0.01% 817
2024
Q1 		$6.91M Buy
540,471
+105,578
+24% +$1.33M ﹤0.01% 905
2023
Q4 		$4.96M Sell
434,893
-80,710
-16% -$754K ﹤0.01% 984
2023
Q3 		$4.47M Buy
515,603
+6,280
+1% +$58.5K ﹤0.01% 1005
2023
Q2 		$3.81M Buy
509,323
+58,430
+13% +$474K ﹤0.01% 1034
2023
Q1 		$4.15M Buy
450,893
+40,547
+10% +$401K ﹤0.01% 1027
2022
Q4 		$4.58M Buy
410,346
+17,550
+4% +$153K ﹤0.01% 1022
2022
Q3 		$3.47M Buy
392,796
+84,282
+27% +$745K ﹤0.01% 1046
2022
Q2 		$2.13M Buy
308,514
+1,093
+0.4% +$9.52K ﹤0.01% 1077
2022
Q1 		$3.13M Buy
307,421
+52,730
+21% +$440K ﹤0.01% 1057
2021
Q4 		$2.34M Buy
254,691
+5,664
+2% +$51.1K ﹤0.01% 1165
2021
Q3 		$2.43M Sell
249,027
-9,155
-4% -$85.7K ﹤0.01% 1162
2021
Q2 		$2.56M Buy
+258,182
New +$2.73M ﹤0.01% 1120

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Amundi's TEVA Position: Q2 2026 in Review

Amundi increased its Teva Pharmaceuticals (TEVA) stake by 9.3% in Q2 2026, buying an estimated $5.47M and bringing the position to 1,929,853 shares worth $65.4M. The position accounts for 0.02% of the portfolio, ranked #554.

Amundi first reported a position in TEVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $101M in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Amundi held 1,929,853 shares of Teva Pharmaceuticals worth $65.4M as of Q2 2026.
  • Amundi bought 164,167 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.47M.
  • Teva Pharmaceuticals made up 0.02% of Amundi's portfolio in Q2 2026, its #554 holding.
  • Amundi first reported a position in Teva Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Teva Pharmaceuticals position peaked at $101M in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.